
MindAffect
Developing a BCI that allows locked-in patients to interact or communicate by controlling a computer with brain signals.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor investor investor | €0.0 | round | |
€230k Valuation: €5.5m | Early VC | ||
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 55 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
MindAffect, founded in 2017 by CEO Ivo de la Rive Box and Professor of Artificial Intelligence Peter Desain, is a health-tech company that develops brain-computer interface (BCI) technology.
The company originates from research conducted at Radboud University. It focuses on creating diagnostic systems for hearing and vision impairments, along with communication aids for patients with severe paralysis, such as those with ALS. MindAffect has developed a patented method that uses flickering stimuli to measure brain responses, allowing for faster and more reliable BCI applications.
One of its key products is the KinderCap, a system designed to test and screen preschool children for hearing and vision problems. The company also offers its core BCI technology as an open-source platform to encourage broader development and application. MindAffect operates in the healthcare technology market, serving both clinical and research clients. The business model involves the development and sale of these specialized diagnostic and communication systems. The company has secured funding to support its research and development efforts, including a €1.1 million round to advance its AI-powered health-tech solutions.
Keywords: Brain-Computer Interface, BCI, Health-Tech, Neuroscience, Medical Diagnostics, Vision Screening, Hearing Tests, Assistive Technology, AI, Neurotechnology